ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,320Medicare Part D Prescriptions Filled, Including Refills

Rank: 81 out of 1206

$470K Total Retail Price of All Prescriptions

Rank: 199 out of 1206

384 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 384 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

18% of this provider’s 384 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 12,205 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$35 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
PRAVASTATIN SODIUM 754 682 1 21
LISINOPRIL 550 513 2 4
FUROSEMIDE 539 522 3 5
OMEPRAZOLE 449 425 4 3
LEVOTHYROXINE SODIUM 430 409 5 2
AMLODIPINE BESYLATE 376 353 6 6
HYDROCODONE-ACETAMINOPHEN 374 326 S3 7 7
HYDROCHLOROTHIAZIDE 329 310 8 11
WARFARIN SODIUM 265 230 9 8
METFORMIN HCL 253 225 10 10
ATENOLOL 239 218 11 14
LANTUS 238 238 12 38
METOPROLOL TARTRATE 224 213 13 9
TRAMADOL HCL 222 213 14 17
FLUOXETINE HCL 213 175 15 52
ZOLPIDEM TARTRATE 213 185 15 25
MELOXICAM 187 174 17 35
GABAPENTIN 182 149 18 18
POLYETHYLENE GLYCOL 3350 173 143 19 31
FENTANYL 155 113 S2 20 51
LOSARTAN POTASSIUM 145 130 21 20
METFORMIN HCL ER 127 107 22 58
CARBIDOPA-LEVODOPA 124 124 23 70
DONEPEZIL HCL 123 123 24 29
FENOFIBRATE 122 119 25 56
CITALOPRAM HBR 120 113 26 16
METOPROLOL SUCCINATE 114 110 27 15
ISOSORBIDE MONONITRATE ER 109 109 28 40
PREDNISONE 107 87 29 28
LOVASTATIN 107 96 29 44
RANITIDINE HCL 105 69 31 23
FAMOTIDINE 103 103 32 65
ATORVASTATIN CALCIUM 100 96 33 13
DIGOXIN 99 94 34 43
PAROXETINE HCL 98 98 35 53
ENALAPRIL MALEATE 89 79 36 45
POTASSIUM CHLORIDE 85 85 37 12
DOXAZOSIN MESYLATE 85 79 37 75
ALLOPURINOL 83 75 39 24
NAMENDA 76 76 40 36
ALENDRONATE SODIUM 74 74 41 19
BENAZEPRIL HCL 72 70 42 39
NABUMETONE 70 58 43 91
KLOR-CON 10 69 69 44 93
RISPERIDONE 68 68 45 74
MORPHINE SULFATE 65 64 S2 46 231
CIPROFLOXACIN HCL 65 62 46 61
AZITHROMYCIN 63 57 48 46
OXYCODONE HCL 62 53 S2 49 107
PROAIR HFA 60 55 50 49
TAMSULOSIN HCL 60 49 50 26
NOVOLOG 59 59 52 100
CLOPIDOGREL 58 51 53 48
GLIPIZIDE 57 57 54 64
OXYCODONE-ACETAMINOPHEN 57 55 S2 54 106
BUPROPION HCL 57 57 54 246
BUPROPION HCL SR 56 53 57 171
INDOMETHACIN 54 52 R 58 329
CARBAMAZEPINE 51 51 59 146
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 10, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.